Is SIGA or SKYE more undervalued in 2026?

CirclFi compares SIGA Technologies Inc. (SIGA) and Skye Bioscience, Inc. (SKYE) using 13 institutional-grade valuation models. SIGA has a Quality of Company score of 10.0/10 while SKYE scores 3.6/10.

Which is a better buy — SIGA or SKYE?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do SIGA and SKYE valuations compare?

SIGA at $4.68 and SKYE at $0.78 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

SIGA vs SKYE Valuation Comparison 2026 — Intrinsic Value Analysis

SIGA

Pharmaceutical Preparations

SIGA Technologies Inc.

Quality

10.0

out of 10

Value Trap

LOW

Price

$4.68

Last close

Models

12/13

Active

SKYE

Pharmaceutical Preparations

Skye Bioscience, Inc.

Quality

3.6

out of 10

Value Trap

LOW

Price

$0.78

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	SIGA Fair Value	SIGA Upside	SKYE Fair Value	SKYE Upside
Bayesian DCF	Intrinsic	$9.98	+113.3%	$0.20	-73.9%
Earnings Power Value	Intrinsic	$4.97	+6.1%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$1.65	-64.8%	$1.84	+137.5%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for SIGA vs SKYE — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

SIGA vs SKYE — Which Stock Is More Undervalued?

SIGA scores higher with a 10.0/10 quality rating vs SKYE's 3.6/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing SIGA Technologies Inc. (SIGA) and Skye Bioscience, Inc. (SKYE) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

SIGA currently trades at $4.68 with a QOC of 10.0/10, while SKYE trades at $0.78 with a QOC of 3.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).